Practice Point CME

Your Sorted CME/CE Activities

Number of search result: 8

Evolving Treatment Strategies in Prostate Cancer: An Interactive Case Studies Program

Activity Details

Evolving Treatment Strategies in Prostate Cancer: An Interactive Case Studies Program

Activity Summary:
New frontiers for prostate cancer therapy continue to be explored, as underscored by evolving principles and new agents in development. To deliver state-of-the-art care, healthcare providers must stay informed regularly of new clinical data and treatment recommendations. There is a need for those who treat prostate cancer to consider expert opinion and guidelines in the context of the needs and beliefs of individual patients, to tailor therapy, and achieve best results.

This educational program will review metastatic, hormone-sensitive prostate cancer, non-metastatic, castration-resistant prostate cancer, and prostate cancer local recurrence.

Faculty:Daniel Petrylak, MD and Srinivas Vourganti, MD

Accreditation Type:AMA, ANCC and ACPE

Launch Date:September 17, 2020

Release Date:September 17, 2020

Expiration Date: August 31, 2021

Estimated Time to Complete Activity:1 Hour

ACCESS THIS ACTIVITY

Reinforcing the Current Diagnosis, Treatment and Management of Multiple Myeloma

Activity Details

Reinforcing the Current Diagnosis, Treatment and Management of Multiple Myeloma

Activity Summary:
Treatment paradigms for multiple myeloma have changed substantially over the last years with many advances in novel therapeutic approaches.

Presented by Dr. Joseph Mikhael of the Translational Genomics Research Institute, City of Hope Cancer Center, and Chief Medical Officer of the International Myeloma Foundation, this certified-CME/CNE 1-hour live webcast will cover recent updates in the standard of care and review the latest approved products and new research for the management of multiple myeloma. At the conclusion of the webcast a live question and answer session will be conducted. The activity will be available for 1 CME/CNE credit hour based on confirmed participation and the completion of an evaluation and posttest.

Faculty:Joseph Mikhael, MD

Accreditation Type:AMA and ANCC

Launch Date:September 21, 2020

Release Date:September 21, 2020

Expiration Date: September 24, 2020

Estimated Time to Complete Activity:1 hour

ACCESS THIS ACTIVITY

Independent Coverage from the American Association for Cancer Research (Virtual Annual Meeting)*

Activity Details

Independent Coverage from the American Association for Cancer Research (Virtual Annual Meeting)*

Activity Summary:
Advances in cancer research unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Clinical Clips will spotlight the latest and most relevant clinical data on the advances in the treatment and management of ovarian cancer with a series of ‘what you need to know in 5-minutes’ videos from data presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting.

Faculty:Robert L. Coleman, M.D., FACOG, FACS

Accreditation Type:AMA and ANCC

Launch Date:April 28, 2020

Release Date:April 28, 2020

Expiration Date: March 31, 2021

Estimated Time to Complete Activity:0.25 Hours per Clip

ACCESS THIS ACTIVITY

Advances in the Management of Chronic Immune Thrombocytopenia in Adults - Updated 9/1/20

Activity Details

Advances in the Management of Chronic Immune Thrombocytopenia in Adults - Updated 9/1/20

Activity Summary:
Chronic immune thrombocytopenia (ITP) is one of the most common causes of thrombocytopenia in adults. Diagnosis of ITP remains one of exclusion, and differential diagnosis with secondary forms is crucial to exclude other forms of thrombocytopenia, which may require a different therapeutic approach. Furthermore, chronic symptomatic ITP necessitates second-line treatments based on highly individualized considerations. Advances in the understanding of the pathogenesis have led to novel therapeutic targets, such as the thrombopoietin receptor agonists to aid in this personalized approach.

These educational Mini Modules will outline recent data on current and emerging treatment options for chronic ITP, including FcRn and spleen tyrosine kinase inhibitors.

Updated information is noted on the slide in the upper right hand corner. Please note that participants who have previously claimed credit for this activity should not claim duplicate credit based on the updates.

Faculty:Hanny Al-Samkari, MD

Accreditation Type:AMA and ANCC

Launch Date:July 31, 2019

Release Date:July 31, 2019

Expiration Date: December 31, 2020

Estimated Time to Complete Activity:.25 Hours or .75 Hours depending on the module

ACCESS THIS ACTIVITY

Atlanta Breast Cancer Symposium Enduring Video Archive

Activity Details

Atlanta Breast Cancer Symposium Enduring Video Archive

Activity Summary:
We are pleased to have recently held the Atlanta Breast Cancer Symposium (ABCS) on April 13, 2019 at the InterContinental Buckhead in Atlanta, Georgia.

There are multiple professional education opportunities in breast cancer across the country. The difference of the ABCS with others is the emphasis in the molecular basis of breast cancer to be applied from early detection to management of advanced disease, beyond induction treatment.

The objective of the symposium is to educate the oncology community on the rapidly evolving field of breast cancer from molecular biology to the development and clinical application of highly specific molecules to interfere with the cellular machinery allowing the cancer cells to survive, proliferate, and spread.

These certified CME/CE enduring video archives, with panel discussions, provide access to the conference including clinical presentation and interactive panel discussions with the faculty and audience.

We hope you enjoy this activity!

Faculty:Rodolfo Bordoni, MD

Accreditation Type:Expired Activity

Launch Date:May 16, 2019

Release Date:May 16, 2019

Expiration Date: April 30, 2020

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Thrombocytopenia in Chronic Liver Disease

Activity Details

Thrombocytopenia in Chronic Liver Disease

Activity Summary:
Thrombocytopenia is a common manifestation among patients with chronic liver disease. In the setting of advanced liver disease, thrombocytopenia may negatively impact patient care by interfering with diagnostic and therapeutic procedures. The development of thrombopoietin agonists has the potential to provide clinicians with new options to improve patient care. However, current guidelines provide limited guidance on the optimal approach to increase platelet counts in patients with chronic liver disease.

These educational Mini Modules will outline the pathophysiologic mechanisms, platelet threshold levels, and other factors that impact the decision to initiate treatment for thrombocytopenia. In addition, the benefits and limitations of current and emerging therapeutic options will be discussed.

Faculty:Fred Poordad, MD

Accreditation Type:Expired Activity

Launch Date:Expired Activity

Release Date:Expired Activity

Expiration Date: Expired Activity

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Therapeutic Advances for Castration Resistant Prostate Cancer: Updates from the 2015 American Society of Clinical Oncology Annual Meeting

Activity Details

Therapeutic Advances for Castration Resistant Prostate Cancer: Updates from the 2015 American Society of Clinical Oncology Annual Meeting

Activity Summary:
Advances in cancer research unfold rapidly. In order to deliver state-of-the-art care, healthcare providers who manage this patient population must stay abreast of data emerging from the major conferences.

These educational Mini Modules will review data on castration resistant prostate cancer (CRPC) presented at the 2015 ASCO. Clinical trial data gives new insight into the timing and scheduling of currently approved agents for CRPC. In addition, investigational approaches to CRCP will be presented, as well as information relating to biomarkers and other methods of guiding day-to-day clinical decision-making in this tough-to-treat population.

Faculty:Michael A. Carducci, MD, FACP, FASCO

Accreditation Type:Expired Activity

Launch Date:Expired Activity

Release Date:Expired Activity

Expiration Date: Expired Activity

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

Novel Therapeutic Approaches to Chronic Lymphocytic Leukemia

Activity Details

Novel Therapeutic Approaches to Chronic Lymphocytic Leukemia

Activity Summary:
Dr. Venugopal and Dr. Karmali provide an expert analysis of recent data for the management and treatment of chronic lymphocytic leukemia presented during the American Society of Clinical Oncology 50th Annual Meeting.*

Faculty:Parameswaran Venugopal, MD and Reem Karmali, MD

Accreditation Type:Expired Activity

Launch Date:Expired Activity

Release Date:Expired Activity

Expiration Date: Expired Activity

Estimated Time to Complete Activity:Expired Activity

ACCESS THIS ACTIVITY

CME/CE Activity Sorter
(Select therapeutic category and activity type of interest and view your sorted activities below)

Your Sorted CME/CE Activities

Evolving Treatment Strategies in Prostate Cancer: An Interactive Case Studies Program

Reinforcing the Current Diagnosis, Treatment and Management of Multiple Myeloma

Independent Coverage from the American Association for Cancer Research (Virtual Annual Meeting)*

Advances in the Management of Chronic Immune Thrombocytopenia in Adults - Updated 9/1/20

Atlanta Breast Cancer Symposium Enduring Video Archive

Thrombocytopenia in Chronic Liver Disease

Therapeutic Advances for Castration Resistant Prostate Cancer: Updates from the 2015 American Society of Clinical Oncology Annual Meeting

Novel Therapeutic Approaches to Chronic Lymphocytic Leukemia